ロード中...
DDIS-20. FASN INHIBITION AS A POTENTIAL TREATMENT TO PREVENT METABOLIC ADAPTATION IN GBM
INTRODUCTION: Response to antiangiogenic therapy (ie bevacizumab) in glioblastoma is mostly transient and without proven survival benefit. Acquired resistance to antiangiogenics is felt to be substantially driven by the hypoxic microenvironment. METHODS: Tumor and matching sera from 12 patients havi...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692931/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.255 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|